Ttbio Corp.

Ttbio Corp.

6493.TWO
Ttbio Corp.TW flagTaipei Exchange
52.00
TWD
-4.20
- -
1.56BMarket Cap
Ttbio Corp.
6493.TWO
(Taipei Exchange)

Recent

price

52.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
- -
- -
4.08
3.93
5.95
6.42
9.24
10.92
10.69
7.18
12.25
16.8
12.76
12.52
- -
Revenue per Share
- -
-0.02
-2.55
-2.74
-0.39
0.23
1.1
1.76
1.52
1.84
0.46
1.6
0.27
0.1
- -
Basic EPS, GAAP
- -
-0.02
-14.92
-4.37
0.85
0.35
1.29
-0.2
1.61
-0.83
1.22
0.35
-1.57
0.66
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
0.96
1.45
3.38
- -
0.48
1.21
0.29
- -
Dividend per Share
- -
- -
7.73
4.9
9.36
9.98
11.02
11.73
11.63
9.82
10.23
11.29
10.19
9.98
- -
Book Value per Share
- -
- -
4.2
5.7
5.61
6.28
7.72
8.97
9.44
8.11
8.93
10.35
9.86
10.08
- -
Tangible Book Value per Share
- -
24
19
24
25
25
25
25
25
25
25
25
25
25
- -
Basic Weighted Avg Shares
- -
- -
79
93
148
160
230
272
267
179
306
419
318
312
399
Sales/Revenue/Turnover
- -
- -
-63.15
-71.59
-9.42
-0.1
8.26
11.95
9.18
-10.4
4.01
9.16
-0.27
-0.73
-5.21
Operating Margin (%)
- -
- -
12
22
25
24
26
29
39
37
37
39
42
39
36
Depreciation Expense
- -
- -
-50
-65
-10
6
27
44
38
46
12
40
7
3
-21
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.28
18.32
17.62
17.46
23.78
- -
Effective Tax Rate (%)
- -
- -
-62.38
-69.62
-6.48
3.53
11.88
16.11
14.25
25.64
3.77
9.5
2.1
0.83
-5.34
Profit Margin (%)
- -
- -
33
66
61
101
110
134
115
117
145
179
161
169
238
Working Capital
- -
- -
6
21
15
19
13
23
42
38
36
38
48
101
83
LT Debt
- -
- -
225
271
264
273
299
320
322
285
295
323
300
295
357
Total Equity
- -
- -
- -
- -
- -
-0.05
- -
- -
- -
-4.9
2.71
7.69
-0.16
-0.36
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
2.49
- -
- -
- -
14.01
3.82
11.13
2.19
1.47
- -
Return on Capital (%)
- -
-16,196.72
-65.88
-48.7
-5.5
2.34
10.45
15.46
13.04
17.15
4.61
14.83
2.49
1.03
-8.03
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
3.44%
5.05%
21.1%
Free Cash Flow
-237.84%
-281.54%
-402.94%
Net Income, GAAP
-60.26%
-179.32%
-922.39%
Sales/Revenue/Turnover
14.48%
21.94%
27.8%
Total Cash Common Dividend
- -
- -
-16.67%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
318
2024
- -
- -
- -
- -
312
2025
- -
- -
- -
- -
399

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.27
2024
- -
- -
- -
- -
0.1
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1.21
2024
- -
- -
- -
- -
0.29
2025
- -
- -
- -
- -
- -
Business
Ttbio Corp. operates both domestically in Taiwan and across global markets, specializing in the creation, distribution, and upkeep of advanced medical equipment under its TTBIO brand. The company primarily offers a diverse range of dental instruments, including high and low-speed handpiece series, essential dental components, service rotors, lubrication systems, and comprehensive electric handpiece setups. Furthermore, Ttbio extends its manufacturing expertise to precision-machined parts and specialized components, catering to critical sectors such as healthcare, automotive, aerospace, security, and computing. Established in 2012, this enterprise is strategically headquartered in Taichung, Taiwan.